2022 annual financial data
BriaCell Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -19,607,684 USD and net income was -34,420,222 USD.
Operating cash flow was -15,874,365 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,607,684 USD
- Net income
- -34,420,222 USD
- Operating cash flow
- -15,874,365 USD